Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilary Wynne

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
British Journal of Clinical Pharmacology|June 18, 2016
Impact of age on long-term anticoagulation and how gender and monitoring setting affect it: implications for decision making and patient managementSalah Abohelaika, Hilary Wynne, Peter Avery, et al.
Age and Ageing|June 21, 2014
Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East EnglandSalah Abohelaika, Farhad Kamali, Peter Avery, et al.
Journal of Thrombosis and Thrombolysis|November 1, 2020
Elderly people are inherently sensitive to the pharmacological activity of rivaroxaban: implications for DOAC prescribingEmmanouela Kampouraki, Salah Abohelaika, Peter Avery, et al.
British Journal of Haematology|August 4, 2017
Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: a randomised clinical trialEmmanouela Kampouraki, Peter J Avery, Hilary Wynne, et al.
Clinical Pharmacology and Therapeutics|March 6, 2004
Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarinFarhad Kamali, Tayyaba Irfan Khan, Barry P King, et al.
European Journal of Haematology|June 28, 2018
Individual and monitoring centre influences upon anticoagulation control of AF patients on warfarin: A longitudinal multi-centre UK-based studySalah Abohelaika, Hilary Wynne, Peter Avery, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
British Journal of Clinical Pharmacology|June 18, 2016
Impact of age on long-term anticoagulation and how gender and monitoring setting affect it: implications for decision making and patient managementSalah Abohelaika, Hilary Wynne, Peter Avery, et al.
Age and Ageing|June 21, 2014
Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East EnglandSalah Abohelaika, Farhad Kamali, Peter Avery, et al.
Journal of Thrombosis and Thrombolysis|November 1, 2020
Elderly people are inherently sensitive to the pharmacological activity of rivaroxaban: implications for DOAC prescribingEmmanouela Kampouraki, Salah Abohelaika, Peter Avery, et al.
British Journal of Haematology|August 4, 2017
Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: a randomised clinical trialEmmanouela Kampouraki, Peter J Avery, Hilary Wynne, et al.
Clinical Pharmacology and Therapeutics|March 6, 2004
Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarinFarhad Kamali, Tayyaba Irfan Khan, Barry P King, et al.
European Journal of Haematology|June 28, 2018
Individual and monitoring centre influences upon anticoagulation control of AF patients on warfarin: A longitudinal multi-centre UK-based studySalah Abohelaika, Hilary Wynne, Peter Avery, et al.
Pageof 2